Encapsula NanoSciences产品代理
Encapsula NanoSciences产品代理
大约 10 年前，Encapsula NanoSciences 最初是一家合同研发公司。我们为政府、制药、生物技术和医疗器械领域的客户完成了许多合同研究和专利尽职调查工作。
Encapsula NanoSciences 与学术研究实验室有着广泛的合作，目前正与一所主要大学的合成化学家和癌症生物学家合作开发新的抗肿瘤化合物，这些化合物需要脂质体递送系统才能在体内给药。
Encapsula NanoSciences 还与食品技术行业合作，探索开发基于脂质的抗菌剂，以解决该行业的各种食品安全问题。
Encapsula NanoSciences 致力于将脂质体和其他脂质纳米颗粒技术引入日常消费品中。
Encapsula NanoSciences is a specialty company focused on providing liposome research, development and manufacturing expertise in the production of lipid-based nanoparticles, also known as liposomes, to clients and partners in both the academic and industrial sectors. Encapsula routinely provides custom laboratory-scale liposome preparations of drug encapsulated liposomes such as Clodrosome® (clodronate liposomes), Encapsome® (plain-control liposomes for clodronate liposomes), Doxosome™ (doxorubicin liposomes), Immunosome™ (reactive liposomes for antibody, protein conjugation), Immunodox™ (reactive liposomes for antibody, protein conjugation containing doxorubicin), Immunogene™ (reactive liposomes for antibody, protein conjugation containing genetic material), Immunofluor™ (reactive liposomes for antibody, protein conjugation containing fluorescent molecules for tracking), Genesome™ (liposomal DNA and RNA), Fluoroliposome™ (fluorescent liposomes), Atpsome™ (ATP liposomes), Cellsome™ (plain liposomes as artificial cell models) and Cosmesome™ (liposomes used in dermatology) to clients in universities and industrial research labs. Encapsula NanoSciences also re
oral liposomal product lines; NanoLife Nutra for pets and NanoLife Tonics for humans.
Encapsula NanoSciences originally started as a contract research and development company about 10 years ago. We have done many contract research and patent due diligence work for clients in government, pharmaceutical, biotechnology and medical devices sectors.
Encapsula NanoSciences has extensive collaboration with academic research laboratories and is currently working with synthetic chemists and cancer biologists at a major university in the development of new anti-tumor compounds which require a liposome delivery system in order to be dosed in vivo.
Encapsula NanoSciences is also working with the food technology industry in exploring the development of lipid-based antimicrobial’s as a solution to a variety of food safety issues in that sector.
Encapsula NanoSciences is dedicated to bringing liposome and other lipid nanoparticle technology into consumer products for daily use.
cently introduced two
